UK patients seek compensation after taking rofecoxibBMJ 2004; 329 doi: https://doi.org/10.1136/bmj.329.7478.1308-a (Published 02 December 2004) Cite this as: BMJ 2004;329:1308
- Clare Dyer, legal correspondent
British lawyers are gearing up to launch a mass compensation claim in the British courts on behalf of hundreds of patients who had strokes or heart attacks after taking the arthritis drug rofecoxib (Vioxx).
Two law firms, Leigh, Day & Co and Irwin Mitchell, investigated the possibility of suing the manufacturer, Merck, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial